Illuminate

The Rogel Cancer Center’s Emerging Leaders Council, launched in 2021, supports early-career faculty. Made up of 15 members, the council gives faculty a voice in sharing their needs with Rogel leadership while helping them learn how the cancer center operates, connect with senior leaders, and develop leadership skills.

Rogel Cancer Center researcher, Nisha D’Silva, BDS, MSD, PhD, explains that cancer neuroscience explores the two-way relationship between cancer and the nervous system, showing how nerves can affect tumor behavior locally and throughout the body.

Rogel Cancer Center is committed to training future cancer researchers and care providers, and this article highlights three outstanding emerging leaders.

Researchers at the Rogel Cancer Center are studying why some breast cancer survivors continue endocrine therapy beyond five years while others stop, aiming to improve survivorship support and coordinated care for patients managing long-term treatment side effects.

Rogel researchers are studying how to improve cancer care for adolescents and young adults ages 15–39, a group facing unique physical, emotional, social, and life-transition challenges. Their work focuses on tailoring treatment and support to better meet the needs of these patients.

Rogel Cancer Center researchers study how epigenetics regulates cancer-related genes, aiming to improve therapies, prevention strategies, and patient outcomes.